Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders (NCT04680130) | Clinical Trial Compass
By InvitationNot Applicable
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
United States500 participantsStarted 2020-11-01
Plain-language summary
The investigators aim to learn more about symptoms suggestive of a neurodegenerative process.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All participants will be over the age of 21
* Have symptoms suggestive of a neurodegenerative and/or related disorder
Exclusion Criteria:
* Participants will be excluded if they have any concurrent illnesses that could account for all of their symptoms, such as traumatic brain injury, encephalitis, strokes or developmental syndromes
* Women that are pregnant or post-partum and breast-feeding will be excluded
* Participants will be excluded if they have any of the following genetic conditions which can increase the chance of cancer: Cowden disease, Lynch syndrome, Hypogammaglobulinemia, Wiskott-Aldrich syndrome and Down's syndrome
* Participants will be excluded if MRI is contraindicated (metal in head, cardiac pace maker, etc), if there is severe claustrophobia, if there are conditions that may confound brain imaging studies (e.g. structural abnormalities, including subdural hematoma, intracranial neoplasm or large cortical infarcts)
* Participants will be excluded if they are medically unstable or are on medications that might affect brain structure or metabolism (e.g. chemotherapy)